アプタマー アフェレシス 核酸医薬の開発|タグシクス・バイオ株式会社

News

2024.1.31
News Release SBI Pharmaceuticals and TAGCyx ANNOUNCES A MILESTONE ACHIEVEMENT OF THE RESEARCH AND DEVELOPMENT COLLABORATION OF INNOVATIVE CANCER THERAPY
2024.1.4
News Release TAGCyx and Toray Launch Joint Research Initiative to Combat Preeclampsia during Pregnancy as Part of Efforts to Stem Japan’s Declining Birthrate
2023.12.12
News Release TAGCyx has executed a joint research and development agreement with Teika Pharmaceutical
2023.11.15
Patents, Articles & Conferences We are pleased to announce that the result of our research on a novel anti IFN-γDNA aptamer treatment for Hunner-type interstitial cystitis with Dr. Yoshiyuki Akiyama, University of Tokyo Hospital and Dr. Yi Luo, University of Iowa, have been accepted and published online in iScience.
2023.10.31
Patents, Articles & Conferences Announcement of presentation at the 43rd Annual Scientific Meeting of the Japanese Society of Ocular Pharmacology (November 11 – 12, 2023)
2023.10.3
Information Science Impact magazine published an article about the treatment for Hunner-type interstitial cystitis using TAGCyx’s aptamer, TAGX-0003.
2023.9.15
Patents, Articles & Conferences Announcement of presentation at the 44th Annual Meeting of the Japanese Society for Apheresis (October 20 – 22, 2023)
2023.9.13
Event We will have a booth V-36 at Japan Healthcare Venture Summit 2023 on Oct 11st-13rd
2023.5.29
Information Announcing the renovating of TAGCyx website
2023.4.18
Patents, Articles & Conferences We will be presenting Apheresis project at ISFA 2023 (June 1st – 3rd at Berlin)
2023.3.30
Patents, Articles & Conferences We will be presenting Hunner-type Interstitial Cystitis project at AUA annual meeting 2023 (April 28th-May 1st at Chicago)
2022.12.23
Event TAGCyx will be attending 41st Annual J.P. Morgan Healthcare Conference